Time-of-drug-addition
Time-of-drug-addition - Related Videos
01:18
Additional Routes of Drug Administration
0 Views •
2023
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used. Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
01:14
Time Course of Drug Effect
0 Views •
2023
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
01:09
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
0 Views •
2026
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:27
Conjugate Addition (1,4-Addition) vs Direct Addition (1,2-Addition)
0 Views •
2025
α,β-Unsaturated carbonyl compounds with two electrophilic sites, the carbonyl carbon, and the β carbon, are susceptible to nucleophilic attack via two modes: conjugate or 1,4-addition and direct or 1,2-addition. Conjugate addition results in a thermodynamically stable product. The reaction retains the stronger C=O bond at the expense of the weaker C=C π bond. The process is slow as the β carbon is less electrophilic than the carbonyl carbon. Direct addition products are formed faster owing to...
01:15
Drug Concentration Versus Time Correlation
0 Views •
2024
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation. Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
FAQs
A compound that remains effective only when added before or soon after infection likely affects an early stage, whereas activity after infection has progressed suggests a later target. Researchers infer the relevant window by comparing pathogen replication or other infection-related outcomes across multiple addition times, rather than relying on a single treatment point.
The timing of activity can associate a compound with broad stages of infection. Early sensitivity may be consistent with effects on entry, while continued sensitivity at later times may indicate effects on genome replication, protein production, assembly, or release. These comparisons provide mechanistic clues, although the method identifies a sensitive stage rather than independently proving a precise molecular target.
Pre-infection and post-infection additions place the compound in different biological contexts. Comparing their effects helps determine whether treatment is most effective before the infectious process starts or after intracellular events are underway. This distinction can separate early effects from later effects and strengthens interpretation of how the candidate compound influences infection progression.
Researchers expose infected cells, or cells scheduled for infection, to the candidate compound at defined times before or after infection. They then measure pathogen replication or another infection-related outcome for each timing condition. Plotting or comparing these results reveals when sensitivity is greatest and helps identify the stage at which treatment has its strongest apparent effect.
The method can use measurements of pathogen replication or other outcomes related to infection. The same type of outcome should be compared across the different addition times so that changes can be attributed to treatment timing. A pattern of reduced replication or altered infection-related results indicates that the compound remains active during particular stages of the process.
The results indicate whether a candidate compound acts most effectively during an early or late portion of the infection cycle. That information can guide the design of therapeutic regimens by identifying when treatment may need to begin and which stage should remain exposed to the drug. It also supports comparison of candidate compounds with different timing profiles in infection research.